Compound comparison
A structured research comparison between SS-31 and NAD+ across compound identity, research category, evidence maturity, and interpretation boundaries.
Mitochondria-targeted tetrapeptide
Investigated in mitochondrial membrane, cardiolipin, redox, and organ-specific mitochondrial dysfunction models.
Developing clinical evidence
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
Redox cofactor
Functions as an established redox cofactor and enzyme substrate across cellular metabolism.
Established evidence base
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
| Dimension | SS-31 | NAD+ |
|---|---|---|
| Catalog identity | SS-31 is mapped to mitochondria-targeted peptide research. | NAD+ is mapped to established redox biochemistry. |
| Research category | SS-31 is primarily organized around mitochondrial dysfunction and cardiolipin-context research. | NAD+ is primarily organized around cellular metabolism and redox biology. |
| Interpretive boundary | Use the SS-31 profile and verified study pages before inferring mechanism or outcomes. | Use the NAD+ profile and verified study pages before inferring mechanism or outcomes. |
Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.
SS-31 and elamipretide literature index
PubMed, U.S. National Library of Medicine · Database
NAD+ metabolism literature index
PubMed, U.S. National Library of Medicine · Database
Atlas internal research database
Internal Research Database · 2026 · Database
Continue the research map